Solebury Trout
Solebury Trout Updates: Solebury Trout Launches Corporate Communications Capabilities For Life Sciences Clients
Solebury Trout

On May 29, 2018 we announced that we added corporate communications services to complement our leading life sciences investor relations practice, giving clients the ability to differentiate and communicate their value propositions to all of their stakeholders, from investors and media to the scientific and medical communities. Brad Miles, founder of BMC Communications, will lead the services, bringing his team and portfolio of life sciences client relationships with him. He will be part of Solebury Trout's broader corporate communications practice serving private and public companies across industry sectors.

"We're thrilled to have Brad and his team join our firm and expand our practice," said Jonathan Fassberg, Co-CEO of Solebury Trout and leader of the firm's life sciences business, which currently has nearly 90 clients. "The combination of an established corporate communications practice, market access abilities and capital markets advisory platform gives Solebury Trout an unmatched ability to reach key stakeholders and maximize shareholder returns for life sciences companies at every stage of development."

Miles joins Solebury Trout as a managing director, reporting to Lisa Wolford, Co-CEO of Solebury Trout and head of the firm's multi-sector corporate communications practice. For more than 20 years, Miles has run BMC Communications, an award-winning corporate communications agency focused exclusively on life sciences, helping more than 100 biopharma clients tell their complex stories—to Wall Street, media and potential partners—to build awareness and value, forge strong alliances, and move their business objectives forward.

"I'm thrilled to have the opportunity to join Solebury Trout," said Miles. "Solebury Trout has been a leader in providing strategic investor relations and market access to life sciences companies for more than two decades. Together we are well-positioned to bring comprehensive investor relations and corporate communications services to leading life sciences companies, helping them achieve their ambitious goals of bringing innovative new treatments to patients in need."